The above data consistently indicated that SLC2A1-DT exerted its function by driving YWHAZ-mediated stabilization of β-catenin, resulting in enhanced glycolysis, proliferation, and metastasis of HCC. The gene discussed is SLC2A1; the disease is hepatocellular carcinoma.